Clinical Trial Update: A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating ABBV-295 subcutaneous injections to assess adverse events and pharmacokinetics in adults with obesity; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ABBV-295

Snippet

Sponsor: AbbVie | Conditions: Obesity | Phase 1 | Status: RECRUITING